Tomorrow's the day where we should get a better concept of how this play works out......    thus far, it's gone as planned.  Thanks, Silverman/Suzman.
  Here's something well-timed.......
  01:28 PM ET 08/23/99
  PCP, Cocaine Vaccination Eyed
   PCP, Cocaine Vaccination Eyed  By JANET McCONNAUGHEY=  Associated Press Writer=            NEW ORLEANS (AP) _ Designer antibodies may someday be used to  immunize people against cocaine and other drugs to block the rush  that users crave.            If these vaccines fulfill their promise, they could  revolutionize emergency treatment for PCP and amphetamines. And  though they won't cure addiction, they could also help people who  want to kick the habit, researchers say.            ''Our goal would be to protect against the sudden unexpected  urge to use, so that if the patient used it, he wouldn't get the  effects,'' said Dr. Michael Owen, a pharmacologist at the  University of Arkansas for Medical Sciences who hopes to begin  tests this year on a PCP overdose treatment.            The illegal drugs all have molecules so tiny they sneak  unnoticed through the body's immune system. To create antibodies,  researchers must hook the molecule to a protein big enough to set  off the immune system's alarms.            The drug-plus-protein can be injected directly, to prompt the  body to make its own antibodies. Or scientists can create the  antibodies by working with laboratory animals and inject them into  patients.            Either way, the antibody grabs the drug in the bloodstream,  before it gets to the brain.            At least, that's how it works in animals so far.            Antibodies could be used to treat an overdose or block a drug's  effects for a longer period, perhaps a month or more.            Both PCP and methamphetamine last for days in the body, unlike  cocaine, which is metabolized in 20 minutes or so.            PCP intoxication can be fatal, and both it and amphetamine  psychosis can leave permanent mental scars, said Frank Vocci, head  of medications development for the National Institute on Drug Abuse  and Alcoholism.            The ability to bind the drugs to antibodies could be a major  leap forward in treating them, he said.            Cocaine addiction is a much bigger and trickier problem. More  than 2 million people need treatment. About 900,000 a year start  treatment, but at least three-quarters go back to the drug, Vocci  said.            ''Maybe if we had something to help them out for the initial  period, it might boost the efficacy keep them in longer,'' he said.            Scientists involved in the research discussed their work Monday  at a meeting of American Chemical Association in New Orleans.            Already, one cocaine vaccine, developed by a biomedical company  in Massachusetts, is being tried on people at a Connecticut clinic.  So far, only the safety has been tested, and it had virtually no  side effects, said Dr. Thomas Kosten, a psychiatry professor at  Yale University and chief of psychiatry for the Veterans  Administration in Connecticut.            The study was not designed to look at the effectiveness of the  vaccine, but a few of the participants reported that cocaine  ''doesn't seem to have the bang that it used to have,'' Kosten  said. |